Can this pharmacy retailer overcome this latest threat?It's been a very difficult year for Walgreens Boots Alliance (WBA 1.99%), which has seen its stock lose two-thirds of its value this year. The company has fallen victim to consistent drops in drug reimbursement payments from insurance providers over the years, a poor acquisition, and a cost-conscious consumer.Now a new threat to the company has emerged: Amazon (AMZN 1.16%).The Amazon threatThe pharmacy business has long been considered e-commerce-proof. ...

Wakgreens logo is seen on a building in New York, United States of America, on July 6th, 2024. ... [+] (Photo by Beata Zawrzel/NurPhoto via Getty Images)NurPhoto via Getty ImagesWalgreens (NASDAQ: WBA) is scheduled to report its fiscal Q4 2024 results on Tuesday, October 15 (Walgreens’ fiscal ends in August). We expect the company to post mixed results, with revenue of $34.9 billion and earnings of $0.38 per share, compared to the consensus estimates of $35.7 billion and $0.36, respectively. While the compa ...

Walgreens stock is down over 65% in 2024 and has been in a downturn for over four yearsShares of Walgreens Boots Alliance Inc (NASDAQ:WBA) are up 0.8% to trade at $8.99 this afternoon, brushing off this morning's price-target cut to $11 from $13 at Deutsche Bank. Wall Street is gearing up for the company's fourth-quarter report, due out before the bell on Tuesday, Oct. 15. Below we'll take a look at the company's post-earnings performance history, as well as a few technical set ups that could indicate poten ...

In its upcoming report, Walgreens Boots Alliance (WBA) is predicted by Wall Street analysts to post quarterly earnings of $0.36 per share, reflecting a decline of 46.3% compared to the same period last year. Revenues are forecasted to be $35.8 billion, representing a year-over-year increase of 1.1%.Over the last 30 days, there has been a downward revision of 2.1% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of t ...

Long-established in the Healthcare Providers & Services industry, Walgreens Boots Alliance Inc (WBA, Financial) has enjoyed a stellar reputation. It has recently witnessed a daily gain of 0.17%, juxtaposed with a three-month change of -13.27%. However, fresh insights from the GF Score hint at potential headwinds. Notably, its diminished rankings in financial strength, growth, and valuation suggest that the company might not live up to its historical performance. Join us as we dive deep into these pivotal me ...

Wall Street expects a year-over-year decline in earnings on higher revenues when Walgreens Boots Alliance (WBA) reports results for the quarter ended August 2024. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on O ...

With yields of 8% or better at recent prices, these dividend payers are hard to ignore.If you're an investor looking for stocks that can produce giant streams of passive income, you may have noticed a couple of well-established dividend payers have been beaten down a long way over the past 12 months.The past year has been a lousy time for holding shares of Walgreens Boots Alliance (WBA 1.72%) and Western Union (WU -0.76%). Both of these dividend payers have been beaten down to near 52-week lows. At their be ...

Core Viewpoint - Walgreens Boots Alliance (WBA) is expected to report a significant decline in earnings for the fourth quarter of fiscal 2024, with a consensus estimate of 36 cents per share, reflecting a 46.3% decrease from the previous year, while revenues are projected to increase slightly by 1.1% to $35.8 billion [2][6]. Financial Performance - The earnings estimate for the fourth quarter has remained stable at 36 cents per share over the past 30 days, indicating a significant drop from the prior year's earnings [2]. - Walgreens has missed earnings estimates twice in the last four quarters, with an average surprise of 10.9% [3][4]. - The company has an Earnings ESP of +10.92%, but currently holds a Zacks Rank of 4 (Sell) [5]. Market Challenges - The company faces macroeconomic challenges, including labor shortages and supply chain disruptions, which have negatively impacted its performance [6]. - Ongoing inflation and reduced household savings have led to a difficult consumer environment, affecting retail sales, which are expected to decline by 0.6% in the upcoming quarter [6]. - Regulatory and reimbursement pressures in the pharmacy industry may have adversely affected pricing dynamics and profitability [7]. Segment Performance - The U.S. Healthcare segment is projected to see a revenue increase of 6.5% year-over-year, driven by Shields Health Solutions [8]. - The International division, particularly Boots U.K., is expected to show a 2% revenue improvement due to strong performance in both physical and digital channels [8]. Cost Management and Strategy - The company anticipates achieving $1 billion in cost savings through its Transformational Cost Management Program, with improvements in cash flow generation [9]. - Walgreens is undergoing a strategic review, planning to close nearly 25% of its underperforming U.S. Retail Pharmacy stores over the next three years [13]. - The company is also evaluating options for its majority stake in VillageMD, which may indicate a shift in strategy regarding value-based primary care [14]. Stock Performance - Walgreens shares have declined by 60.9% over the past year, significantly underperforming the industry and the S&P 500 [10]. - The stock is currently trading at a forward P/E ratio of 4.92X, lower than the industry average of 8.30X [12]. Future Outlook - The company is focusing on building an asset-light health services strategy and enhancing its digital offerings to better serve customers [15]. - Despite promising long-term initiatives, immediate operational challenges may hinder strong performance in the final quarter of fiscal 2024 [16].

Earnings and Market Sentiment - Walgreens Boots Alliance (WBA) is expected to report its Q4 FY24 earnings on October 15, 2024, pre-market [1] - The analyst anticipates potential disappointments in the upcoming earnings report, even if there is an upside surprise [1] Investment Strategy and Portfolio Management - The analyst manages a family portfolio primarily through a Self Managed Super Fund, focusing on alpha-generating investment ideas [1] - The investment approach is generalist, targeting any sector with perceived alpha potential compared to the S&P 500 [1] - Typical holding periods range from a few quarters to multiple years [1] Disclosure and Author Background - The analyst holds a beneficial long position in VOO through stock ownership, options, or other derivatives [2] - The article reflects the analyst's personal opinions and is not compensated by any company mentioned [2]

I noted on X late last year that Walgreens (NASDAQ: WBA ) was the standout, notoriously so, “Dow of the Dow.” That’s a moniker and category for components of the Dow Jones Industrial Average that sport the largest dividend yields. Market writersFreelance Financial Writer | Investments | Markets | Personal Finance | RetirementI create written content used in various formats including articles, blogs, emails, and social media for financial advisors and investment firms in a cost-efficient way. My passion is p ...